3737 — Zhongzhi Pharmaceutical Holdings Balance Sheet
0.000.00%
- HK$794.51m
- HK$822.74m
- CNY2.21bn
- 72
- 89
- 29
- 72
Annual balance sheet for Zhongzhi Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 295 | 242 | 396 | 167 | 167 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 285 | 307 | 318 | 336 | 448 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 884 | 857 | 1,091 | 874 | 1,014 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 458 | 551 | 574 | 676 | 733 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,421 | 1,524 | 1,875 | 1,793 | 1,987 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 485 | 501 | 731 | 609 | 732 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 600 | 625 | 872 | 744 | 871 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 820 | 899 | 1,003 | 1,049 | 1,117 |
Total Liabilities & Shareholders' Equity | 1,421 | 1,524 | 1,875 | 1,793 | 1,987 |
Total Common Shares Outstanding |